Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the diagnostic accuracy of 1) CSF tau, 2) CSF p-tau, 3) the CSF tau/ABeta ratio and 4) the CSF p-tau/ABeta ratio index tests at various thresholds for detecting participants with mild cognitive impairment (MCI) at baseline who would clinically convert to Alzheimer's disease or other forms of dementia at follow-up. To investigate the amount of and associations of heterogeneity in the included studies of test accuracy. We expect that heterogeneity will be likely and that it will be an important component of the review. The potential sources of heterogeneity, which will be used as a framework for the investigation of heterogeneity, include target population, index test, target disorder and study quality.

Original publication




Journal article


Cochrane Database of Systematic Reviews

Publication Date